Description

Palbociclib 125mg Capsule (Palbocent) – Uses, Side Effects, Dosage & Price in Pakistan

Palbociclib 125mg Capsule (Palbocent) is a prescription targeted cancer medicine containing palbociclib. It belongs to a class of medicines known as cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors. Palbociclib is used as part of combination treatment for certain hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) advanced or metastatic breast cancers.

Palbociclib works by interfering with CDK4 and CDK6 proteins involved in cell-cycle progression. This can help slow the growth and division of cancer cells. The medicine is generally used with endocrine therapy, such as an aromatase inhibitor or fulvestrant, according to the patient’s diagnosis and treatment plan.

For patients in Pakistan looking for information about Palbociclib, it is important to understand its uses, dosage, possible side effects, precautions, monitoring requirements, and purchasing considerations. Impo Medic provides medicine information to help patients understand prescription oncology treatments before discussing them with their healthcare team.

Palbociclib 125mg Capsule (Palbociclib) Used For

Palbociclib is indicated for adults with certain HR-positive, HER2-negative advanced or metastatic breast cancers.

It may be used:

• In combination with an aromatase inhibitor as endocrine-based therapy.
• In combination with fulvestrant in patients whose disease has progressed after previous endocrine therapy.
• With appropriate endocrine therapy in premenopausal or perimenopausal women, where an LHRH agonist is also used according to the treatment plan.

The selection of treatment depends on hormone receptor status, HER2 status, previous treatment, menopausal status, disease stage, and the patient’s overall medical condition.

Palbociclib should not be started without assessment by an oncologist experienced in the use of anticancer medicines.

HR-Positive, HER2-Negative Breast Cancer

HR-positive breast cancer has receptors for hormones that can contribute to cancer-cell growth. HER2-negative breast cancer does not show HER2 overexpression or amplification according to the relevant diagnostic assessment.

Palbociclib is designed for selected HR-positive, HER2-negative advanced or metastatic breast cancers and is generally used with endocrine therapy rather than as a stand-alone treatment for its approved indications.

How Palbociclib 125mg Capsule (Palbociclib) Works

Palbociclib is a selective inhibitor of CDK4 and CDK6. These enzymes are involved in regulating the cell cycle and help cells progress from the G1 phase toward the S phase.

Some hormone receptor-positive breast cancer cells depend on this pathway for continued growth and division. By inhibiting CDK4/6 activity, palbociclib can interfere with cell-cycle progression and reduce the proliferation of susceptible cancer cells.

Palbociclib is commonly combined with endocrine therapy because the combination can interfere with cancer-cell growth through complementary mechanisms. The exact combination is selected by the treating oncologist according to the patient’s cancer and previous treatment.

Palbociclib 125mg Dosage

The recommended starting dose of Palbociclib is 125mg once daily for 21 consecutive days followed by 7 days off treatment, making a complete 28-day cycle. It is taken orally with food.

The usual schedule can be summarized as:

• Days 1–21: Palbociclib 125mg once daily
• Days 22–28: No palbociclib
• Next cycle: The schedule starts again if the oncologist continues treatment

Treatment may continue while the patient is receiving clinical benefit and does not develop unacceptable toxicity.

The dose may need to be interrupted, delayed, or reduced because of side effects, particularly blood-cell abnormalities. Lower doses may be prescribed when medically necessary. Patients should never change their dose without instructions from their oncologist.

How Palbociclib 125mg Capsule Is Taken

Palbociclib should be taken exactly as prescribed by the treating healthcare professional.

Important instructions include:

• Take the prescribed dose once daily on the scheduled treatment days.
• Take Palbociclib with food.
• Try to take the medicine at approximately the same time each day.
• Swallow the capsule as directed.
• Follow the 21-days-on and 7-days-off schedule prescribed by your doctor.
• Do not take an additional dose if you vomit after taking a dose.
• If a dose is missed or vomiting occurs, take the next prescribed dose at the usual time rather than taking an extra dose.

The treatment schedule may be adjusted by the oncologist according to blood counts, side effects, response to treatment, and other clinical factors.

Palbociclib 125mg Side Effects

Palbociclib can cause side effects, and some may be related to its effect on the bone marrow and blood-cell production.

Possible side effects include:

• Neutropenia
• Leukopenia
• Infections
• Anemia
• Thrombocytopenia
• Fatigue
• Nausea
• Stomatitis or mouth sores
• Hair loss
• Diarrhea
• Rash
• Vomiting
• Reduced appetite
• Weakness
• Fever

Neutropenia is one of the most important adverse reactions associated with Palbociclib. The current prescribing information also lists infections, leukopenia, fatigue, nausea, stomatitis, anemia, alopecia, diarrhea, thrombocytopenia, rash, vomiting, decreased appetite, asthenia, and fever among common adverse reactions.

The severity of side effects can vary from patient to patient and may also depend on the other cancer medicines being used.

Serious Side Effects and Warnings

Palbociclib has important warnings concerning neutropenia and interstitial lung disease (ILD)/pneumonitis. It can also cause fetal harm.

Low White Blood Cell Counts

Palbociclib can significantly reduce neutrophil counts. Neutrophils are white blood cells that help the body fight infections.

Doctors usually perform complete blood counts before treatment and at specified points during therapy. Treatment may be interrupted or the dose reduced if blood counts become too low.

Contact your healthcare team promptly if you develop:

• Fever or chills
• Sore throat
• Signs of infection
• Unusual weakness
• Unexplained bruising
• Unusual bleeding

Lung Problems

Interstitial lung disease and pneumonitis, including severe and potentially fatal cases, have been reported with palbociclib.

Seek medical attention if you develop new or worsening:

• Difficulty breathing
• Shortness of breath
• Persistent cough
• Chest discomfort
• Other unexplained respiratory symptoms

The prescribing information recommends prompt evaluation when ILD or pneumonitis is suspected.

Embryo-Fetal Toxicity

Palbociclib can cause fetal harm. Patients who can become pregnant should discuss effective contraception with their healthcare professional before and during treatment.

Precautions Before Using Palbociclib 125mg

Before starting Palbociclib 125mg Capsule, tell your doctor about your complete medical history.

Special attention may be required if you have:

• Low blood-cell counts
• Recurrent or serious infections
• Lung disease or breathing problems
• Liver problems
• Kidney problems
• Previous serious medicine reactions
• Pregnancy or plans to become pregnant
• Breastfeeding
• Other ongoing medicines or supplements

Your oncologist may order blood tests and other assessments before and during treatment.

Palbociclib treatment should be initiated and supervised by a physician experienced in anticancer therapy.

Palbociclib 125mg Drug Interactions

Palbociclib is metabolized mainly through the CYP3A pathway, so certain medicines can affect its concentration in the body.

Strong CYP3A inhibitors can increase palbociclib exposure, while strong CYP3A inducers can decrease its exposure and potentially reduce its effectiveness. The prescribing information provides specific recommendations for managing these interactions.

Tell your doctor about:

• Prescription medicines
• Over-the-counter medicines
• Vitamins
• Herbal products
• Supplements

Do not start or stop another medicine without discussing it with your healthcare provider during Palbociclib treatment.

Palbociclib 125mg During Pregnancy

Palbociclib can cause fetal harm and should be avoided during pregnancy unless the treating healthcare professional determines that its use is medically appropriate.

Patients who can become pregnant should discuss effective contraception with their healthcare provider. Patients should also inform their doctor if pregnancy occurs during treatment.

Breastfeeding should also be discussed with the treating healthcare professional because the safety of palbociclib during breastfeeding requires consideration of the potential risk to the infant.

Palbociclib 125mg Monitoring

Regular monitoring is an important part of treatment with Palbociclib 125mg Capsule.

Complete blood counts are used to monitor neutrophils and other blood cells. The current prescribing information recommends blood-count monitoring before treatment, at the beginning of each cycle, and on Day 15 of the first two cycles, as well as when clinically indicated.

If significant abnormalities occur, the oncologist may:

• Temporarily interrupt treatment
• Delay the next dose
• Reduce the dose
• Permanently discontinue treatment in specific circumstances

Regular follow-up helps the healthcare team balance treatment benefit with safety.

Palbociclib 125mg Capsule Storage

Palbociclib should be stored according to the instructions provided with the specific product.

Keep the capsules:

• In their original packaging
• Away from unsuitable temperatures and moisture
• Away from the reach of children
• According to the storage instructions printed on the product packaging

Patients should not use capsules after their expiry date.

Because different manufacturers may have different product information and packaging requirements, always follow the storage instructions supplied with Palbocent.

Palbociclib 125mg Price in Pakistan

The Palbociclib 125mg Capsule (Palbocent) price in Pakistan can vary depending on supplier, manufacturer, pack size, availability, import conditions, and market fluctuations.

Specialized oncology medicines may have different prices between suppliers, so patients should confirm the latest price and availability before purchasing.

For Pakistan-based medicine information and availability, patients can contact Impo Medic to check the current product details.

The exact price should always be confirmed before placing an order because medicine prices and availability can change in the Pakistani market.

How to Buy Palbociclib 125mg Capsule in Pakistan

Patients looking to buy Palbociclib 125mg Capsule (Palbocent) in Pakistan should obtain it through a reliable medicine supplier and according to a valid prescription from their healthcare professional.

When purchasing Palbociclib, confirm:

• Product name and strength
• Generic name
• Manufacturer
• Pack size
• Batch number
• Expiry date
• Packaging condition
• Storage requirements
• Authenticity of the medicine

Impo Medic can be contacted for information about Palbociclib 125mg Capsule availability in Pakistan. Since this is a prescription oncology medicine, patients should use it only according to the treatment plan provided by their oncologist.

Avoid purchasing cancer medicines from unverified sources simply because they offer a lower price. Authenticity, correct storage, and proper product identification are important for prescription oncology medicines.

Frequently Asked Questions About Palbociclib 125mg Capsule (Palbociclib)

What is Palbociclib 125mg Capsule (Palbociclib) used for?

Palbociclib 125mg is used with endocrine therapy for certain HR-positive, HER2-negative advanced or metastatic breast cancers. It may be combined with an aromatase inhibitor or fulvestrant depending on the treatment setting.

Is Palbociclib a chemotherapy medicine?

Palbociclib is a targeted anticancer medicine and CDK4/6 inhibitor rather than a conventional cytotoxic chemotherapy drug. It works by interfering with CDK4 and CDK6 proteins involved in cell-cycle progression.

What is the usual Palbociclib 125mg dose?

The recommended starting dose is 125mg once daily for 21 consecutive days followed by 7 days off treatment, forming a 28-day cycle. Palbociclib is taken with food.

How should Palbociclib 125mg be taken?

Palbociclib should be taken orally with food at approximately the same time each day. Patients should follow the prescribed 21-day treatment period followed by 7 days off unless their oncologist gives different instructions.

Can Palbociclib cause low white blood cells?

Yes. Neutropenia and leukopenia are important adverse effects of Palbociclib. Regular complete blood-count monitoring is therefore an important part of treatment.

What should I do if I miss a Palbociclib dose?

If a dose is missed or you vomit after taking Palbociclib, do not take an additional dose that day. The next prescribed dose should be taken at the usual time.

Can Palbociclib cause lung problems?

Yes. Interstitial lung disease and pneumonitis have been reported, including serious cases. New or worsening breathing problems, persistent cough, or shortness of breath should be reported promptly to the healthcare team.

Can Palbociclib be used during pregnancy?

Palbociclib can cause fetal harm. Patients who can become pregnant should discuss effective contraception with their healthcare professional and inform their doctor if pregnancy occurs during treatment.

Can I stop Palbociclib if I feel better?

No. Do not stop or change Palbociclib treatment without speaking with your oncologist. The treatment schedule is determined according to the cancer type, treatment response, laboratory results, and side effects.

Where can I buy Palbociclib 125mg in Pakistan?

Palbociclib 125mg should be purchased from a reliable medicine supplier or pharmacy with a valid prescription. Patients can contact Impo Medic to check current availability and purchasing information in Pakistan.

Is Palbocent the same as other Palbociclib brands?

Palbocent and other products containing palbociclib may contain the same active ingredient, but different brands can have different manufacturers, packaging, authorization details, and excipients. Patients should confirm the specific product with their pharmacist or healthcare provider before switching brands.

Does Palbociclib require regular blood tests?

Yes. Complete blood counts are an important part of monitoring because Palbociclib can reduce neutrophils and other blood cells. The prescribing information recommends blood-count monitoring before treatment and at specified points during therapy.